PubMed ID:
23357210
Public Release Type:
Journal
Publication Year: 2013
Affiliation: Social & Scientific Systems, Inc., Silver Spring, Maryland 20910, USA. cfwu@s-3.com
DOI:
https://doi.org/10.1016/j.juro.2013.01.061
Authors:
Eggers PW,
Fwu CW,
Kaplan SA,
Kirkali Z,
Kusek JW,
Lee JY
Studies:
Medical Therapy of Prostatic Symptoms
We examined the effects of doxazosin, finasteride and combination therapy among men with benign prostatic hyperplasia on quality of life assessed with MOS-SF-36 (Medical Outcomes Study Short-Form 36) and 2 disease specific instruments (BII, benign prostatic hyperplasia Impact Index and I-PSS-QoL, International Prostate Symptom Score-QoL) during 4 years.